Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Preventing Cardiovascular Collapse With Administration of Fluid Resuscitation During Induction and Intubation

ClinicalTrials.gov ID: NCT03787732

Public ClinicalTrials.gov record NCT03787732. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 7, 2026, 10:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Preventing Cardiovascular Collapse With Administration of Fluid Resuscitation During Induction and Intubation (PREPARE II Trial)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Complications are common during tracheal intubation of critically ill patients. Nearly one in five patients undergoing intubation in the intensive care unit experiences cardiovascular collapse, defined as severe hypotension, vasopressor administration, cardiac arrest or death. Cardiovascular collapse during intubation is associated with increased resource utilization and decreased survival. Administration of 500 mL of intravenous crystalloid solution beginning prior to induction may prevent cardiovascular collapse. The only prior trial examining fluid bolus administration during intubation found no effect on cardiovascular collapse or clinical outcomes overall, but a hypothesis-generating subgroup analysis suggested potential benefit to fluid bolus administration among patients receiving positive pressure ventilation between induction and laryngoscopy. Therefore, we propose a randomized trial comparing fluid bolus administration versus none with regard to cardiovascular collapse among critically adults undergoing intubation with positive pressure ventilation between induction and laryngoscopy.

Study identification

NCT ID
NCT03787732
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Enrollment
1,067 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2019
Primary completion
May 23, 2021
Completion
Jun 20, 2021
Last update posted
Aug 11, 2021

2019 – 2021

United States locations

U.S. sites
11
U.S. states
10
U.S. cities
10
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233
Louisiana State University School of Medicine New Orleans Louisiana 70112
Ochsner Medical Center | Ochsner Health System New Orleans Louisiana 70121
Lahey Hospital & Medical Center Burlington Massachusetts 01805
Hennepin County Medical Center Minneapolis Minnesota 55415
University of Mississippi Medical Center Jackson Mississippi 39216
Wake Forest Baptist Medical Center Winston-Salem North Carolina 27157
Oregon Health & Science University Portland Oregon 97239
Vanderbilt University Medical Center Nashville Tennessee 37209
Baylor Scott & White Medical Center - Temple Temple Texas 76508
University of Washington Seattle Washington 98195

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Recently updated Acute Respiratory Failure trials

Other public records listing Acute Respiratory Failure. Sorted by last update posted; newest first. Not a recommendation.

All Acute Respiratory Failure trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03787732, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 11, 2021 · Synced Sep 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03787732 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →